You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 158 No. 2, February 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Infectious Diseases
 •Viral Infections
 •Pediatrics, Other
 •Alert me on articles by topic

Managing Bronchiolitis and Respiratory Syncytial Virus

Finding the Yellow Brick Road

Arch Pediatr Adolesc Med. 2004;158:111-112.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In this issue of the ARCHIVES, the 2 studies by Bordley et al1 and King et al2 clearly point out the conundrums, confusion, and concerns regarding the currently available methods of diagnosis and testing as well as pharmacologic therapies for bronchiolitis in young children. These well-designed reviews conclude that the present indications for testing and efficacy of the therapeutic modalities discussed are insufficient. The results produce 2 major questions: Why is no benefit or efficacy demonstrated, and where do we go from here?

The lack of effective approaches to management may result partly from differences in design and outcome measures in the various studies. Perhaps more important, the populations being studied are not uniform (clinically, demographically, environmentally, or genetically). For instance, corticosteroids do not appear to benefit children who are first-time wheezers but may be indicated in those with recurrent wheezing.3 Children from families with a history of atopy may . . . [Full Text of this Article]

Caroline Breese Hall, MD
Departments of Pediatrics and Medicine, Infectious Diseases, Box 689
University of Rochester School of Medicine and Dentistry
601 Elmwood Ave
Rochester, NY 14642
(e-mail: Caroline_Hall@urmc.rochester.edu)


RELATED ARTICLES

Diagnosis and Testing in Bronchiolitis: A Systematic Review
W. Clayton Bordley, Meera Viswanathan, Valerie J. King, Sonya F. Sutton, Anne M. Jackman, Laura Sterling, and Kathleen N. Lohr
Arch Pediatr Adolesc Med. 2004;158(2):119-126.
ABSTRACT | FULL TEXT  

Pharmacologic Treatment of Bronchiolitis in Infants and Children: A Systematic Review
Valerie J. King, Meera Viswanathan, W. Clayton Bordley, Anne M. Jackman, Sonya F. Sutton, Kathleen N. Lohr, and Timothy S. Carey
Arch Pediatr Adolesc Med. 2004;158(2):127-137.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Limited Role of Tests for Pediatric Bronchiolitis and Drugs to Treat It
JWatch General 2004;2004:5-5.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.